文獻(xiàn)：
1、" Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature. "
Pharmacotherapy 2007;27:290–8. Page RL, Schwiesow J, Hilts A.
2、Mucormycosis treated with posaconazole: review of 96 case reports.
Crit Rev Microbiol 2013;39:310–24. Vehreschild JJ, Birtel A, Vehreschild MJGT, et al.
3、Tarantino MD, Fogarty P, Mayer B, Vasey SY, Brainsky A. Efficacy of eltrombopag in management of bleeding symptoms associated with chronic immune thrombocytopenia. Blood Coagul Fibrinolysis. 2013 Apr;24(3):284-96. doi: 10.1097/MBC.0b013e32835fac99.
4、J Med Chem, 51: 4632～4640.
Org. Process Res. Dev. 2019, 23, 9, 2057-2068
Pharmazie 73(9):494-497 · September 2018
5、中國醫(yī)藥工業(yè)雜志 2012， 43（8）， 644-646
6、精細(xì)化工中間體2013，43（2），46-48
7、精細(xì)化工中間體2011，41（4），46-48
8、中國現(xiàn)代應(yīng)用藥學(xué)2011，28（1），58-59
9、Chemical biology&Drug Design 2014, 83(3), 306-316
10、Letters in organic chemistry 2012, 9(4), 276-279
11、Medicines Evidence Commentary : Chronic kidney disease: calcium-based versus non-calcium-based phosphate binders
Source: National Institute for Health and Care Excellence - NICE - 21 January 2014 - Publisher: National Institute for Health and Care Excellence (NICE)
12、double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children
13、J. Med. Chem. 2018, 61, 5304?5322.
14、Chem. Biol. Drug Des. 2014, 83, 306?316.
15、J. Pharm. Biomed. Anal. 2009, 50, 144?150.
16、Int. J. Pharm. Sci. 2016, 8, 97?102.
17、J. Pharm. Biomed. Anal. 2010, 52, 493?507.
18、Org. Process Res. Dev. 2013, 17, 1036?1041.
19、Beilstein J. Org. Chem. 2011, 7, 442? 495.
20、Bioorg. Med. Chem. Lett. 2014, 24, 1108?1110.
21、New Activated PEG Derivatives for Affinity Partitioning
22、Population incidence and mortality of sepsis in an urban African setting 2013-2016
23、Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in
[更多]
渝公網(wǎng)安備 50010802001068號(hào)
